Antiflu Avigan not showing apparent efficacy in coronavirus treatment

Avigan, a candidate drug for treating novel coronavirus infections, has not shown apparent efficacy in treating the respiratory disease in clinical trials so far, raising doubts about its approval by the end of this month as sought by the Japanese government, sources familiar with the matter said Tuesday.Interim results of clinical tests of Avigan on COVID-19 patients reported to the health ministry did not provide clear evidence of the drug's effectiveness in reducing coronavirus growth, they said.Japanese Prime Minister Shinzo Abe has said he is hoping for the approval of Avigan, develope…READ FULL ARTICLE